(Q41445876)

English

Prognostic significance of programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) Expression in epithelial-originated cancer: a meta-analysis

scientific article published on February 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 September 2017

0 references

1 reference

Europe PubMed Central

Prognostic significance of programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) Expression in epithelial-originated cancer: a meta-analysis (English)

1 reference

Europe PubMed Central

30 September 2017

author name string

Yaxiong Zhang

1

1 reference

Europe PubMed Central

30 September 2017

Shiyang Kang

2

1 reference

Europe PubMed Central

30 September 2017

Jianfei Shen

3

1 reference

Europe PubMed Central

30 September 2017

Jiaxi He

4

1 reference

Europe PubMed Central

30 September 2017

Long Jiang

5

1 reference

Europe PubMed Central

30 September 2017

Wei Wang

6

1 reference

Europe PubMed Central

30 September 2017

Zhihua Guo

7

1 reference

Europe PubMed Central

30 September 2017

Guilin Peng

8

1 reference

Europe PubMed Central

30 September 2017

Gang Chen

9

1 reference

Europe PubMed Central

30 September 2017

Jianxing He

10

1 reference

Europe PubMed Central

30 September 2017

Wenhua Liang

11

1 reference

Europe PubMed Central

30 September 2017

language of work or name

0 references

publication date

1 February 2015

1 reference

Europe PubMed Central

30 September 2017

1 reference

Europe PubMed Central

30 September 2017

94

1 reference

Europe PubMed Central

30 September 2017

6

1 reference

Europe PubMed Central

30 September 2017

e515

1 reference

Europe PubMed Central

30 September 2017

PD-L1 expression in nonclear-cell renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Programmed death ligand-1 expression in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

B7-H1 expression is associated with poor prognosis in colorectal carcinoma and regulates the proliferation and invasion of HCT116 colorectal cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Inhibitory B7-family molecules in the tumour microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Practical methods for incorporating summary time-to-event data into meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

The new B7s: playing a pivotal role in tumor immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Checkpoint blockade in cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Operating characteristics of a rank correlation test for publication bias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

1 October 2017

Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

11 June 2018

T-cell infiltration and expressions of T lymphocyte co-inhibitory B7-H1 and B7-H4 molecules among colorectal cancer patients in northeast China's Heilongjiang province

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

11 June 2018

Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

19 August 2018

Significance of programmed cell death-ligand 1 expression and its association with survival in patients with small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

19 August 2018

Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

19 August 2018

Costimulatory molecule B7-H1 on the immune escape of bladder cancer and its clinical significance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

19 August 2018

Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602735

19 August 2018

Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: a 5-year-follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Expression of B7-H1 protein in human pancreatic carcinoma tissues and its clinical significance]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of B7-H1 and B7-1 expressions in pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Significance of the Costimulatory Molecule B7-H1 in Barrett Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/MD.0000000000000515

1 reference

Europe PubMed Central

30 September 2017

1 reference

Europe PubMed Central

30 September 2017

1 reference

Europe PubMed Central

30 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41445876&oldid=2097812875"